ROAP-AdOAP in Acute Adult Leukemia
Publication Information Expand/Collapse
Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328
Minority report: how best to analyze clinical trial data to address disparities
Long-term survival after chemotherapy for acute myeloid leukemia: The experience of the Southwest Oncology Group.
Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia-results of a Southwest Oncology Group study of rubidazone vs adriamycin for remission induction, prophylactic intrathecal therapy, late intensifica- tion, and levamisole maintenance.
Institutional performance in application of the FAB classification of acute leukemia: the Southwest Oncology Group experience.
Reproducibility of the French-American-British classification of acute leukemia. A Southwest Oncology Group experience.
The incidence of hand-mirror cells in acute myeloblastic and lymphoblastic leukemia
The prevalence of hand-mirror cells in acute myeloblastic and lymphoblastic leukemia
Nonspecific esterase cytochemistry in acute myeloblastic leukemia: alpha-naphthyl acetate versus alpha-naphthyl butyrate
The effect of lumbar puncture in the incidence of meningeal leukemia. A Southwest Oncology Group study.
A comparison of Rubidazone and Adriamycin used in a multidrug regimen for remission induction in acute leukemia. A Southwest Oncology Group study.
Acute non-lymphocytic leukemia (ANLL) in adults: remission reinduction with adriamycin, ctyosine arabinoside, oncovin and prednisone (ADOAP)
Treatment of adult acute myeloblastic leukemia.